The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation

Geoffrey J. Clark, Michael S. Kinch, Kelley Rogers-Graham, Said M. Sebti, Andrew Hamilton, Channing J. Der

Research output: Contribution to journalArticle

Abstract

Presently, nothing is known about the function of the Ras-related protein Rheb. Since Rheb shares significant sequence identity with the core effector domains of Ras and KRev-1/Rap1A, it may share functional similarities with these two structurally related, yet functionally distinct, small GTPases. Furthermore, since like Ras, Rheb terminates with a COOH terminus that is likely to signal for farnesylation, it may be a target for the farnesyltransferase inhibitors that block Ras processing and function. To compare Rheb function with those of Ras and KRev-1, we introduced mutations into Rheb that generate constitutive]y active or dominant negative forms of Ras and Ras-related proteins and were designated Rheb(64L) and Rheb(20N), respectively. Expression of wild type or mutant Rheb did not alter the morphology or growth properties of NIH 3T3 cells. Thus, aberrant Rheb function is distinct from that of Ras and fails to cause cellular transformation. Instead, similar to KRev-1, co-expression of Rheb antagonized oncogenic Ras transformation and signaling. In vitro and in vivo analyses showed that like Ras, Rheb proteins are farnesylated and are sensitive to farnesyltransferase inhibition. Thus, it is possible that Rheb function may be inhibited by farnesyltransferase inhibitors treatment and, consequently, may contribute to the ability of these inhibitors to impair Ras transformation.

Original languageEnglish (US)
Pages (from-to)10608-10615
Number of pages8
JournalJournal of Biological Chemistry
Volume272
Issue number16
DOIs
StatePublished - Apr 18 1997

Fingerprint

Farnesyltranstransferase
ras Proteins
Prenylation
NIH 3T3 Cells
Proteins
Monomeric GTP-Binding Proteins
Mutation
Growth
Processing

ASJC Scopus subject areas

  • Biochemistry

Cite this

The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. / Clark, Geoffrey J.; Kinch, Michael S.; Rogers-Graham, Kelley; Sebti, Said M.; Hamilton, Andrew; Der, Channing J.

In: Journal of Biological Chemistry, Vol. 272, No. 16, 18.04.1997, p. 10608-10615.

Research output: Contribution to journalArticle

Clark, Geoffrey J. ; Kinch, Michael S. ; Rogers-Graham, Kelley ; Sebti, Said M. ; Hamilton, Andrew ; Der, Channing J. / The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation. In: Journal of Biological Chemistry. 1997 ; Vol. 272, No. 16. pp. 10608-10615.
@article{51e359ce79b44daebeb8fe57dd25d941,
title = "The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation",
abstract = "Presently, nothing is known about the function of the Ras-related protein Rheb. Since Rheb shares significant sequence identity with the core effector domains of Ras and KRev-1/Rap1A, it may share functional similarities with these two structurally related, yet functionally distinct, small GTPases. Furthermore, since like Ras, Rheb terminates with a COOH terminus that is likely to signal for farnesylation, it may be a target for the farnesyltransferase inhibitors that block Ras processing and function. To compare Rheb function with those of Ras and KRev-1, we introduced mutations into Rheb that generate constitutive]y active or dominant negative forms of Ras and Ras-related proteins and were designated Rheb(64L) and Rheb(20N), respectively. Expression of wild type or mutant Rheb did not alter the morphology or growth properties of NIH 3T3 cells. Thus, aberrant Rheb function is distinct from that of Ras and fails to cause cellular transformation. Instead, similar to KRev-1, co-expression of Rheb antagonized oncogenic Ras transformation and signaling. In vitro and in vivo analyses showed that like Ras, Rheb proteins are farnesylated and are sensitive to farnesyltransferase inhibition. Thus, it is possible that Rheb function may be inhibited by farnesyltransferase inhibitors treatment and, consequently, may contribute to the ability of these inhibitors to impair Ras transformation.",
author = "Clark, {Geoffrey J.} and Kinch, {Michael S.} and Kelley Rogers-Graham and Sebti, {Said M.} and Andrew Hamilton and Der, {Channing J.}",
year = "1997",
month = "4",
day = "18",
doi = "10.1074/jbc.272.16.10608",
language = "English (US)",
volume = "272",
pages = "10608--10615",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "16",

}

TY - JOUR

T1 - The Ras-related protein Rheb is farnesylated and antagonizes Ras signaling and transformation

AU - Clark, Geoffrey J.

AU - Kinch, Michael S.

AU - Rogers-Graham, Kelley

AU - Sebti, Said M.

AU - Hamilton, Andrew

AU - Der, Channing J.

PY - 1997/4/18

Y1 - 1997/4/18

N2 - Presently, nothing is known about the function of the Ras-related protein Rheb. Since Rheb shares significant sequence identity with the core effector domains of Ras and KRev-1/Rap1A, it may share functional similarities with these two structurally related, yet functionally distinct, small GTPases. Furthermore, since like Ras, Rheb terminates with a COOH terminus that is likely to signal for farnesylation, it may be a target for the farnesyltransferase inhibitors that block Ras processing and function. To compare Rheb function with those of Ras and KRev-1, we introduced mutations into Rheb that generate constitutive]y active or dominant negative forms of Ras and Ras-related proteins and were designated Rheb(64L) and Rheb(20N), respectively. Expression of wild type or mutant Rheb did not alter the morphology or growth properties of NIH 3T3 cells. Thus, aberrant Rheb function is distinct from that of Ras and fails to cause cellular transformation. Instead, similar to KRev-1, co-expression of Rheb antagonized oncogenic Ras transformation and signaling. In vitro and in vivo analyses showed that like Ras, Rheb proteins are farnesylated and are sensitive to farnesyltransferase inhibition. Thus, it is possible that Rheb function may be inhibited by farnesyltransferase inhibitors treatment and, consequently, may contribute to the ability of these inhibitors to impair Ras transformation.

AB - Presently, nothing is known about the function of the Ras-related protein Rheb. Since Rheb shares significant sequence identity with the core effector domains of Ras and KRev-1/Rap1A, it may share functional similarities with these two structurally related, yet functionally distinct, small GTPases. Furthermore, since like Ras, Rheb terminates with a COOH terminus that is likely to signal for farnesylation, it may be a target for the farnesyltransferase inhibitors that block Ras processing and function. To compare Rheb function with those of Ras and KRev-1, we introduced mutations into Rheb that generate constitutive]y active or dominant negative forms of Ras and Ras-related proteins and were designated Rheb(64L) and Rheb(20N), respectively. Expression of wild type or mutant Rheb did not alter the morphology or growth properties of NIH 3T3 cells. Thus, aberrant Rheb function is distinct from that of Ras and fails to cause cellular transformation. Instead, similar to KRev-1, co-expression of Rheb antagonized oncogenic Ras transformation and signaling. In vitro and in vivo analyses showed that like Ras, Rheb proteins are farnesylated and are sensitive to farnesyltransferase inhibition. Thus, it is possible that Rheb function may be inhibited by farnesyltransferase inhibitors treatment and, consequently, may contribute to the ability of these inhibitors to impair Ras transformation.

UR - http://www.scopus.com/inward/record.url?scp=0030888163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030888163&partnerID=8YFLogxK

U2 - 10.1074/jbc.272.16.10608

DO - 10.1074/jbc.272.16.10608

M3 - Article

VL - 272

SP - 10608

EP - 10615

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 16

ER -